Bioversys To Present At H.C. Wainwright 28Th Annual Global Investment Conference
BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (MDR) bacteria, announced today that management will present a corporate overview at the H.C. Wainwright 28th Annual Global Investment Conference, held on September 14-16, 2026 in New York City, NY.
BioVersys Session
Presenter: Hernan Levett, Chief Financial Officer, BioVersys
Date: September 16, 2026, 12.30pm – 1.00pm ET
Location: Kennedy II (4th Floor), Lotte New York Palace, New York City, NY
BioVersys On Demand
Presenter: Dr. Marc Gitzinger, Chief Executive Officer, BioVersys
Date: Live September 11, 2026 at 7.00AM ET; replay available for 90 days
Webcast Link: Accessible on the H.C. Wainwright Platform or on the BioVersys website in the investor section.
BioVersys' CEO and CFO will be available for meetings during the conference. Registered attendees can request one-on-one meetings with BioVersys by contacting their representative at H.C. Wainwright.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment